Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares Bought by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its stake in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 3.2% during the fourth quarter, HoldingsChannel reports. The firm owned 586,710 shares of the biopharmaceutical company’s stock after purchasing an additional 18,043 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Akebia Therapeutics were […]
